Pharmaceutical
Ended Awarded
- Contract number
- VA77016J1428
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $478,860
Award facts
- Contract value 100% obligated
- $478,860.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Ardsley, NY 10502, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms.
The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued at over $16.3 million, which facilitates the procurement of the company's drugs and pharmaceuticals through September 2024. Acorda also holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, valued at $5.5 million and $7.5 million, specifically for the procurement of Inbrija and Ampyra, the company's medications for Parkinson's disease and multiple sclerosis. These contracting vehicles provide a streamlined process for VA medical facilities to order Acorda's neurological products to support the agency's mission of providing quality healthcare to veterans. The contract does not have a set-aside designation, indicating Acorda competed on an unrestricted basis.
Quick answers
Who was awarded contract VA77016J1428?
VA77016J1428 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on July 29, 2016.
How much is contract VA77016J1428 worth?
The government has obligated $478,860 on VA77016J1428.
Which agency awarded contract VA77016J1428?
Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77016J1428, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).
Is contract VA77016J1428 an order under another contract?
Yes. VA77016J1428 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA77016J1428 competed?
The extent of competition for VA77016J1428 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award